Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thoracic paravertebral block plus intravenous dexmedetomidine in medical thoracoscopy
PACTR202005777730971Phase 4Recruiting
- Sponsor
- Maaly Group
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine in Pleural disease (2 arms), sponsored by Maaly Group. Started Apr 2020; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Pleural disease
Beyond the preview
Go deeper on PACTR202005777730971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202005777730971.